Lan Tan
#125,475
Most Influential Person Now
Researcher
Lan Tan's AcademicInfluence.com Rankings
Lan Tanengineering Degrees
Engineering
#4102
World Rank
#5268
Historical Rank
Electrical Engineering
#1021
World Rank
#1097
Historical Rank
Lan Tancomputer-science Degrees
Computer Science
#5243
World Rank
#5537
Historical Rank
Computational Linguistics
#686
World Rank
#698
Historical Rank
Machine Learning
#1314
World Rank
#1334
Historical Rank
Artificial Intelligence
#1553
World Rank
#1582
Historical Rank
Download Badge
Engineering Computer Science
Lan Tan's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Lan Tan Influential?
(Suggest an Edit or Addition)Lan Tan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
- Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. (2015) (781)
- The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis. (2016) (492)
- Microglia in Alzheimer's Disease (2014) (484)
- Post-stroke cognitive impairment: epidemiology, mechanisms and management. (2014) (440)
- Meta-analysis of modifiable risk factors for Alzheimer's disease (2015) (372)
- Apolipoprotein E in Alzheimer's disease: an update. (2014) (341)
- Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. (2014) (323)
- The cost of Alzheimer's disease in China and re-estimation of costs worldwide (2018) (312)
- Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis (2014) (227)
- The NLRP3 Inflammasome in Alzheimer’s Disease (2013) (209)
- Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease (2014) (209)
- Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy (2014) (208)
- Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies (2015) (207)
- Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease (2014) (202)
- Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy (2014) (201)
- Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis. (2015) (201)
- Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies (2019) (195)
- The role of the LRRK2 gene in Parkinsonism (2014) (191)
- Circulating miR-125b as a biomarker of Alzheimer's disease (2014) (185)
- Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials (2019) (180)
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. (2014) (172)
- Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. (2014) (170)
- Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors. (2013) (167)
- Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy (2015) (167)
- Nutrition and the Risk of Alzheimer's Disease (2013) (166)
- Cognitive Reserve and Alzheimer’s Disease (2015) (164)
- Non-coding RNAs in Alzheimer's Disease (2013) (163)
- Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies (2017) (160)
- The Role of Cdk5 in Alzheimer’s Disease (2016) (158)
- Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies (2019) (158)
- Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies (2016) (153)
- Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease. (2013) (149)
- Calcium dysregulation in Alzheimer's disease: From mechanisms to therapeutic opportunities (2009) (149)
- Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies. (2018) (146)
- Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease. (2014) (139)
- Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies (2016) (138)
- The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy (2012) (133)
- Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy (2015) (131)
- Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis (2014) (130)
- Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy (2015) (128)
- The Prevalence of Dementia: A Systematic Review and Meta-Analysis. (2019) (127)
- Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis. (2014) (124)
- TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice (2016) (123)
- NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model (2015) (119)
- Association between stroke and Alzheimer's disease: systematic review and meta-analysis. (2015) (117)
- APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis (2014) (115)
- The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations (2012) (115)
- Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population (2013) (112)
- Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy (2018) (112)
- Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy (2013) (112)
- Rate of early onset Alzheimer's disease: a systematic review and meta-analysis. (2015) (107)
- TREM2 in Alzheimer’s disease (2013) (106)
- Resveratrol as a Therapeutic Agent for Alzheimer's Disease (2014) (105)
- The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients (2010) (102)
- Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis (2019) (100)
- Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy (2014) (99)
- Behavioral and Psychological Symptoms in Alzheimer's Disease (2014) (98)
- Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases (2014) (98)
- Depression in Alzheimer's disease: epidemiology, mechanisms, and management. (2014) (97)
- Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance (2014) (96)
- Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies (2017) (93)
- Role of the mTOR signaling pathway in epilepsy (2013) (92)
- Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease (2014) (90)
- The prevalence of depression in Alzheimer's disease: a systematic review and meta-analysis. (2015) (89)
- Ischemic Preconditioning Provides Neuroprotection by Induction of AMP-Activated Protein Kinase-Dependent Autophagy in a Rat Model of Ischemic Stroke (2015) (88)
- Biomarkers for preclinical Alzheimer's disease. (2014) (85)
- Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice (2014) (83)
- The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention (2021) (82)
- Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses. (2015) (81)
- Novel disease-modifying therapies for Alzheimer's disease. (2012) (80)
- CD33 in Alzheimer's Disease (2014) (80)
- Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease (2015) (79)
- The Role of ADAM10 in Alzheimer's Disease. (2017) (79)
- The Role of PICALM in Alzheimer’s Disease (2015) (78)
- NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese (2013) (78)
- The Role of SORL1 in Alzheimer’s Disease (2014) (78)
- Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis. (2015) (78)
- A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese (2016) (77)
- Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus (2014) (75)
- TYROBP in Alzheimer’s Disease (2015) (74)
- Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice (2015) (74)
- Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. (2013) (73)
- The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease (2016) (73)
- IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice. (2013) (73)
- Angiotensin‐(1–7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS‐dependent pathway (2014) (73)
- Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials (2018) (71)
- FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study (2019) (69)
- Non-pharmacological interventions for patients with mild cognitive impairment: a meta-analysis of randomized controlled trials of cognition-based and exercise interventions. (2014) (65)
- Autophagy Modulation for Alzheimer’s Disease Therapy (2013) (65)
- Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease (2012) (64)
- Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. (2010) (64)
- Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia (2015) (63)
- Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals (2014) (62)
- Axonal Transport Defects in Alzheimer’s Disease (2014) (62)
- Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease (2009) (61)
- Heat Shock Protein 70 in Alzheimer's Disease (2014) (61)
- Endoplasmic Reticulum Dysfunction in Alzheimer’s Disease (2015) (61)
- Clusterin in Alzheimer's disease. (2012) (61)
- TREM1 facilitates microglial phagocytosis of amyloid beta (2016) (60)
- Polymorphisms at the β2-adrenergic receptor gene influence Alzheimer's disease susceptibility (2008) (60)
- Microglial priming in Alzheimer's disease. (2018) (59)
- Heat Shock Protein 90 in Alzheimer's Disease (2014) (59)
- Anticonvulsant effect of unilateral anterior thalamic high frequency electrical stimulation on amygdala-kindled seizures in rat (2012) (59)
- White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies (2020) (58)
- The Role of Cholesterol Metabolism in Alzheimer’s Disease (2014) (56)
- Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer’s Disease (2016) (56)
- The Role of TDP-43 in Alzheimer’s Disease (2016) (56)
- Deep brain stimulation for epilepsy in clinical practice and in animal models (2011) (56)
- Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. (2011) (56)
- DMT1 polymorphism and risk of Parkinson’s disease (2011) (55)
- Genetics of Vascular Dementia: Systematic Review and Meta-Analysis. (2015) (54)
- The link between the SNCA gene and parkinsonism (2015) (54)
- Genome-wide microRNA expression profiles in hippocampus of rats with chronic temporal lobe epilepsy (2014) (53)
- Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease (2010) (51)
- Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. (2012) (51)
- Association of body mass index with risk of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies (2020) (50)
- Association between cancer and Alzheimer's disease: systematic review and meta-analysis. (2014) (50)
- Roles of β-adrenergic receptors in Alzheimer's disease: Implications for novel therapeutics (2011) (48)
- MS4A Cluster in Alzheimer’s Disease (2014) (48)
- CR1 in Alzheimer's Disease (2015) (48)
- The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy (2016) (47)
- Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. (2014) (47)
- Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum (2016) (46)
- Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese (2011) (46)
- Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease (2012) (46)
- Bridging Integrator 1 (BIN1) Genotype Effects on Working Memory, Hippocampal Volume, and Functional Connectivity in Young Healthy Individuals (2015) (45)
- Application of next-generation sequencing technologies in Neurology. (2013) (45)
- MicroRNAs dysregulation in epilepsy (2014) (45)
- Innate immune activation in Alzheimer's disease. (2018) (44)
- Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta‐analysis of prospective cohort studies (2019) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- S-Nitrosylation in Alzheimer's disease (2015) (44)
- Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis. (2016) (44)
- Meta-Analysis of Peripheral Blood Apolipoprotein E Levels in Alzheimer’s Disease (2014) (43)
- An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease (2013) (42)
- Blood Pressure and Risks of Cognitive Impairment and Dementia (2020) (42)
- Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis (2015) (41)
- Early-Life Risk Factors for Dementia and Cognitive Impairment in Later Life: A Systematic Review and Meta-Analysis. (2019) (40)
- Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: The CABLE study (2020) (40)
- A Mitocentric View of Alzheimer’s Disease (2017) (40)
- Mode-dependent effect of high-frequency electrical stimulation of the anterior thalamic nucleus on amygdala-kindled seizures in rats (2012) (39)
- Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha. (2008) (39)
- Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study (2020) (38)
- Meta-analysis of the association between variants in MAPT and neurodegenerative diseases (2017) (38)
- Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study (2019) (38)
- Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study. (2019) (38)
- PGRN Is Associated with Late-Onset Alzheimer’s Disease: a Case–Control Replication Study and Meta-analysis (2017) (37)
- State of Play in Alzheimer's Disease Genetics. (2017) (37)
- Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease (2014) (37)
- Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats. (2013) (37)
- Risk factors for intracranial atherosclerosis: A systematic review and meta-analysis. (2019) (36)
- TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice (2017) (36)
- Blocking β2-adrenergic receptor attenuates acute stress-induced amyloid β peptides production (2010) (36)
- Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases (2015) (36)
- Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese (2011) (35)
- Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals (2014) (35)
- Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis. (2015) (34)
- Prion-like Mechanisms in Alzheimer's Disease. (2014) (34)
- Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese (2013) (34)
- Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration. (2016) (33)
- Association of TOMM40 Polymorphisms with Late-Onset Alzheimer’s Disease in a Northern Han Chinese Population (2013) (33)
- Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
- Common variants in toll-like receptor 4 confer susceptibility to Alzheimer's disease in a Han Chinese population. (2012) (33)
- TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. (2019) (33)
- Toll-like receptor 2 -196 to -174 del polymorphism influences the susceptibility of Han Chinese people to Alzheimer's disease (2011) (32)
- Age-related hearing loss accelerates cerebrospinal fluid tau levels and brain atrophy: a longitudinal study (2019) (32)
- Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review. (2019) (32)
- Midlife Modifiable Risk Factors for Dementia: A Systematic Review and Meta-analysis of 34 Prospective Cohort Studies. (2020) (32)
- Tau-tubulin kinase-1 gene variants are associated with Alzheimer's disease in Han Chinese (2011) (31)
- Association of IL-12A and IL-12B polymorphisms with Alzheimer's disease susceptibility in a Han Chinese population (2014) (31)
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
- Diffusion-weighted magnetic resonance imaging demonstrates parenchymal pathophysiological changes in epilepsy (2008) (31)
- C9ORF72 Mutations in Neurodegenerative Diseases (2014) (28)
- ABCA7 in Alzheimer’s Disease (2014) (28)
- Plasma Angiotensin-(1-7) is a Potential Biomarker for Alzheimer's Disease. (2016) (28)
- Genome-Wide microRNA Profiling of Rat Hippocampus after Status Epilepticus Induced by Amygdala Stimulation Identifies Modulators of Neuronal Apoptosis (2013) (27)
- Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. (2019) (27)
- The Role of Reelin Signaling in Alzheimer’s Disease (2016) (27)
- Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease. (2015) (27)
- Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. (2015) (27)
- SORCS1 and APOE polymorphisms interact to confer risk for late-onset Alzheimer's disease in a Northern Han Chinese population (2012) (27)
- Genetic association of TLR4/11367 polymorphism with late-onset Alzheimer's disease in a Han Chinese population (2011) (26)
- Toward precision medicine in neurological diseases. (2016) (26)
- Interleukin-18 promoter polymorphisms and risk of ischemic stroke (2010) (26)
- Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia (2020) (25)
- Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis (2017) (25)
- Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese (2013) (25)
- Genome-wide association studies in neurology. (2013) (25)
- Low-frequency stimulation of bilateral anterior nucleus of thalamus inhibits amygdale-kindled seizures in rats (2011) (24)
- TMEM106B and APOE polymorphisms interact to confer risk for late-onset Alzheimer’s disease in Han Chinese (2013) (24)
- Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. (2018) (24)
- Association between late-onset Alzheimer's disease and microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene (2011) (24)
- Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese (2011) (24)
- The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations (2013) (23)
- Neuropeptide Y polymorphisms and ischemic stroke in Chinese population. (2010) (23)
- Heat Shock Proteins at the Crossroads between Cancer and Alzheimer's Disease (2014) (23)
- Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study (2020) (23)
- Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels (2019) (23)
- Body fluid biomarkers in Alzheimer's disease. (2015) (23)
- Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives. (2016) (22)
- Exploring the value of plasma BIN1 as a potential biomarker for alzheimer's disease. (2013) (22)
- Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies (2020) (22)
- Genetic variation in PICALM and Alzheimer's disease risk in Han Chinese (2014) (22)
- β-Arrestins as Potential Therapeutic Targets for Alzheimer’s Disease (2013) (22)
- Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration (2021) (21)
- The role of the immune system in Alzheimer’s disease (2021) (21)
- Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis (2021) (21)
- Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer’s disease: A systematic review and meta-analysis (2021) (21)
- Missense variants in CR1 are associated with increased risk of Alzheimer' disease in Han Chinese (2014) (21)
- Interleukin-23 receptor polymorphisms are associated with Alzheimer's disease in Han Chinese (2014) (21)
- GWAS-Linked Loci and Neuroimaging Measures in Alzheimer’s Disease (2015) (21)
- Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults (2019) (21)
- Association of Parkinson’s Disease GWAS-Linked Loci with Alzheimer’s Disease in Han Chinese (2015) (21)
- Insulin-like growth factor 1 (IGF1) polymorphism is associated with Alzheimer's disease in Han Chinese (2012) (21)
- PLD3 in Alzheimer’s Disease (2015) (20)
- The Role of PGRN in Alzheimer’s Disease (2016) (20)
- Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study (2020) (20)
- Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese (2011) (19)
- Cognitive Effects of Treating Obstructive Sleep Apnea: A Meta-Analysis of Randomized Controlled Trials. (2020) (19)
- Genetic Association of SLC2A14 Polymorphism with Alzheimer’s Disease in a Han Chinese Population (2012) (19)
- Genetic association between ADAM10 gene polymorphism and Alzheimer's disease in a Northern Han Chinese population (2011) (19)
- Tau pathologies mediate the association of blood pressure with cognitive impairment in adults without dementia: The CABLE study (2021) (18)
- Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer’s Disease (2017) (18)
- Identification of novel drug targets for Alzheimer’s disease by integrating genetics and proteomes from brain and blood (2021) (18)
- Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients (2014) (18)
- Soluble TREM1 concentrations are increased and positively correlated with total tau levels in the plasma of patients with Alzheimer’s disease (2019) (17)
- Activation of double-stranded RNA-dependent protein kinase inhibits proliferation of pancreatic β-cells. (2014) (17)
- Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease (2021) (17)
- Inflammatory markers in Alzheimer's disease and mild cognitive impairment: A meta‐analysis and systematic review of 170 studies (2020) (17)
- SIRT2 polymorphism rs10410544 is associated with Alzheimer's disease in a Han Chinese population (2014) (16)
- Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts (2015) (16)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Common variant in PTK2B is associated with late-onset Alzheimer’s disease: A replication study and meta-analyses (2016) (16)
- Association of Cerebral Microbleeds with Cognitive Decline: A Longitudinal Study. (2020) (16)
- INPP5D rs35349669 polymorphism with late-onset Alzheimer's disease: A replication study and meta-analysis (2016) (16)
- Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis (2022) (16)
- Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease. (2015) (15)
- ZCWPW1 is associated with late-onset Alzheimer's disease in Han Chinese: a replication study and meta-analyses (2016) (15)
- Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer’s Disease in Han Chinese (2016) (14)
- Elevated plasma levels of soluble TNFRs and TACE activity in Alzheimer's disease patients of Northern Han Chinese descent. (2013) (14)
- The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer’s Disease (2016) (14)
- [Effect of UGT1A6 genetic polymorphisms on the metabolism of sodium valproate]. (2007) (14)
- Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer’s Disease Cohorts (2017) (14)
- Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study. (2021) (14)
- Selective neuronal vulnerability in Alzheimer’s disease (2020) (14)
- Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI. (2016) (14)
- Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study (2020) (14)
- Age-dependent association of KIBRA gene polymorphism with Alzheimer’s disease in Han Chinese (2013) (14)
- The Role of Retromer in Alzheimer’s Disease (2016) (14)
- The genetic variation of ARRB2 is associated with late-onset Alzheimer's disease in Han Chinese. (2014) (13)
- MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures (2016) (13)
- Genome-wide association study identifies two loci influencing plasma neurofilament light levels (2018) (13)
- Single nucleotide polymorphism rs1333049 on chromosome 9p21.3 is associated with Alzheimer's disease in Han Chinese. (2010) (13)
- Systems biology and gene networks in Alzheimer’s disease (2019) (13)
- Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management. (2022) (13)
- Corrigendum to: "The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis" [J. Affect. Disord. 190 (2016) 264-271]. (2016) (13)
- Environmental factors and risks of cognitive impairment and dementia: A systematic review and meta-analysis (2021) (13)
- Associations of Infectious Agents with Alzheimer's Disease: A Systematic Review and Meta-Analysis. (2020) (13)
- Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment (2017) (13)
- Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia (2020) (13)
- ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology. (2016) (13)
- Tauopathies: Mechanisms and Therapeutic Strategies. (2017) (13)
- Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease. (2021) (12)
- Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease (2020) (12)
- Replication of the MTHFD1L gene association with late-onset Alzheimer's disease in a Northern Han Chinese population. (2012) (12)
- Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese (2016) (12)
- Common variant in GAB2 is associated with late-onset Alzheimer's disease in Han Chinese. (2011) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies (2016) (12)
- Genome-wide association study of hippocampal atrophy rate in non-demented elders (2019) (12)
- Spreading of Pathology in Alzheimer’s Disease (2017) (12)
- Amyloid Pathologies Modulate the Associations of Minimal Depressive Symptoms With Cognitive Impairments in Older Adults Without Dementia (2020) (11)
- A Missense Variant in TREML2 Reduces Risk of Alzheimer’s Disease in a Han Chinese Population (2017) (11)
- Endovascular Treatment Versus Intravenous Thrombolysis for Acute Ischemic Stroke: a Quantitative Review and Meta-Analysis of 21 Randomized Trials (2017) (11)
- Herpesvirus infections and Alzheimer’s disease: a Mendelian randomization study (2021) (11)
- Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity (2018) (11)
- Genetic association of rs11610206 SNP on chromosome 12q13 with late-onset Alzheimer's disease in a Han Chinese population. (2011) (11)
- A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia (2020) (11)
- Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study (2019) (11)
- MEF2C rs190982 polymorphism with late-onset Alzheimer's disease in Han Chinese: A replication study and meta-analyses (2016) (11)
- Lack of association between PCDH11X genetic variation and late-onset Alzheimer's disease in a Han Chinese population (2010) (11)
- No association of toll-like receptor 2 polymorphisms with Alzheimer's disease in Han Chinese (2011) (11)
- Distinct neurological disorders with C9orf72 mutations: genetics, pathogenesis, and therapy (2016) (11)
- Genome-Wide Association Study of Cerebral Microbleeds on MRI (2019) (11)
- Genome-wide association study identifies RBFOX1 locus influencing brain glucose metabolism. (2018) (10)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Elevated homocysteine as an independent risk for intracranial atherosclerotic stenosis (2019) (10)
- Cerebral Microinfarcts and Dementia: A Systematic Review and Metaanalysis. (2017) (10)
- The Vulnerability of Vessels Involved in the Role of Embolism and Hypoperfusion in the Mechanisms of Ischemic Cerebrovascular Diseases (2016) (10)
- Association of Occupational Factors and Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis. (2020) (10)
- The role of UNC5C in Alzheimer's disease. (2018) (10)
- Association of LRRTM3 polymorphisms with late-onset Alzheimer's disease in Han Chinese (2014) (10)
- Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders (2016) (10)
- Associations of the neutrophil to lymphocyte ratio with intracranial artery stenosis and ischemic stroke (2021) (9)
- Common Variant in TREM1 Influencing Brain Amyloid Deposition in Mild Cognitive Impairment and Alzheimer’s Disease (2019) (9)
- Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology (2020) (9)
- Plasma Neurofilament Light and Longitudinal Progression of White Matter Hyperintensity in Elderly Persons Without Dementia. (2020) (9)
- Lack of association between COMT Val158Met polymorphism and late-onset Alzheimer's disease in Han Chinese (2013) (9)
- Associations of sleep characteristics with alpha‐synuclein in cerebrospinal fluid in older adults (2020) (9)
- Blood Pressure and the Risk of Dementia: A Dose-Response Meta-Analysis of Prospective Studies. (2019) (9)
- NEDD9 is genetically associated with Alzheimer's disease in a Han Chinese population (2011) (9)
- Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease (2018) (9)
- Activation of adenosine receptor potentiates the anticonvulsant effect of phenytoin against amygdala kindled seizures. (2015) (8)
- Genome-wide association study of cerebrospinal fluid neurofilament light levels in non-demented elders. (2019) (8)
- Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese. (2018) (8)
- Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer’s Disease (2020) (8)
- Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study (2020) (8)
- Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer's Disease. (2018) (8)
- Strong Association of Lipid Metabolism Related MicroRNA Binding Sites Polymorphisms with the Risk of Late Onset Alzheimer's Disease. (2017) (7)
- Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study. (2021) (7)
- Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology (2021) (7)
- Elevated Hs-CRP Levels Are Associated with Higher Risk of Intracranial Arterial Stenosis (2019) (7)
- The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex (2021) (7)
- Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology (2022) (7)
- Tau Toxicity in Neurodegeneration (2022) (7)
- Association of peripheral neutrophil count with intracranial atherosclerotic stenosis (2020) (7)
- Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET (2021) (7)
- Lack of association between rs597668 polymorphism near EXOC3L2 and late-onset Alzheimer's disease in Han Chinese (2012) (7)
- Risk factors for subjective cognitive decline: the CABLE study (2021) (7)
- Time spent in outdoor light is associated with the risk of dementia: a prospective cohort study of 362094 participants (2022) (7)
- Meta-analysis of the association between CD33 and Alzheimer's disease. (2018) (7)
- Impact of SORL1 genetic variations on MRI markers in non-demented elders (2016) (7)
- Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study (2020) (7)
- Apolipoprotein B/AI ratio as an independent risk factor for intracranial atherosclerotic stenosis (2019) (7)
- Metabolically healthy obesity and risk of stroke: a meta-analysis of prospective cohort studies (2021) (7)
- [Effects of three-stage rehabilitation treatment on acute cerebrovascular diseases: a prospective, randomized, controlled, multicenter study]. (2004) (6)
- Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. (2020) (6)
- Lack of Association Between SLC24A4 Polymorphism and Late-onset Alzheimer's Disease in Han Chinese. (2016) (6)
- Association of Serum Complement C1q Concentration with Severity of Neurological Impairment and Infarct size in Patients with Acute Ischemic Stroke. (2020) (6)
- ABCA7 genotype altered Aβ levels in cerebrospinal fluid in Alzheimer's disease without dementia. (2018) (6)
- MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders (2019) (6)
- Portable fibrobronchoscopic treatment for non-severe ischemic stroke-associated pneumonia patients with dysphagia: a pilot study (2019) (6)
- TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration (2019) (6)
- A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid (2018) (6)
- Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood (2022) (6)
- Intranasal anticonvulsive treatment: a prospective management of intractable epilepsy? (2008) (6)
- NME8 rs2718058 polymorphism with Alzheimer's disease risk: a replication and meta-analysis (2016) (6)
- Associations of Subsyndromal Symptomatic Depression with Cognitive Decline and Brain Atrophy in Elderly Individuals without Dementia: A Longitudinal Study. (2020) (6)
- The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases (2020) (6)
- Carotid stenting versus endarterectomy. (2008) (6)
- Fasting glucose and HbA1c levels as risk factors for the presence of intracranial atherosclerotic stenosis. (2019) (6)
- Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer’s disease (2021) (6)
- Microglia Biomarkers in Alzheimer’s Disease (2021) (6)
- Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts (2016) (6)
- Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders (2019) (6)
- HLA-A2 Alleles Mediate Alzheimer’s Disease by Altering Hippocampal Volume (2017) (6)
- SORL1 Is Associated with the Risk of Late-Onset Alzheimer’s Disease: a Replication Study and Meta-Analyses (2017) (6)
- FERMT2 rs17125944 polymorphism with Alzheimer's disease risk: a replication and meta-analysis (2016) (6)
- The Infarct Shape Predicts Progressive Motor Deficits in Patients with Acute Lacunae-sized Infarctions in the Perforating Arterial Territory. (2015) (6)
- Single nucleotide polymorphism rs7294919 on chromosome 12q24.22 is associated with late-onset Alzheimer's disease in Han Chinese (2014) (5)
- Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese. (2018) (5)
- Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic. (2016) (5)
- Association of Subjective Cognitive Decline with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Longitudinal Studies (2021) (5)
- The impact of GAB2 genetic variations on cerebrospinal fluid markers in Alzheimer's disease. (2018) (5)
- Role of Blood Pressure Management in Stroke Prevention: A Systematic Review and Network Meta-Analysis of 93 Randomized Controlled Trials (2021) (5)
- Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study (2021) (5)
- The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers. (2021) (5)
- Identifying Candidate Genetic Associations with MRI-Derived AD-Related ROI via Tree-Guided Sparse Learning (2019) (5)
- Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study. (2021) (5)
- The Association of MME microRNA Binding Site Polymorphism with the Risk of Late Onset Alzheimer's Disease in Northern Han Chinese. (2017) (5)
- Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population. (2016) (5)
- Metabolically healthy obesity and lipids may be protective factors for pathological changes of alzheimer’s disease in cognitively normal adults (2021) (5)
- Association study of the PLXNA4 gene with the risk of Alzheimer's disease. (2016) (5)
- Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease (2019) (5)
- Investigating causal relationships between exposome and human longevity: a Mendelian randomization analysis (2020) (5)
- Association of DISC1 Polymorphisms with Late-Onset Alzheimer’s Disease in Northern Han Chinese (2017) (5)
- High pulse pressure is a risk factor for prodromal Alzheimer’s disease: a longitudinal study (2020) (4)
- Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. (2021) (4)
- Weight Loss is a Preclinical Signal of Cerebral Amyloid Deposition and Could Predict Cognitive Impairment in Elderly Adults. (2020) (4)
- Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study (2020) (4)
- Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study (2022) (4)
- Lifestyle changes might prevent Alzheimer's disease. (2015) (4)
- Genome-wide association study identifies SIAH3 locus influencing the rate of ventricular enlargement in non-demented elders (2019) (4)
- Association of Alzheimer’s disease risk variants on the PICALM gene with PICALM expression, core biomarkers, and feature neurodegeneration (2020) (4)
- Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. (2021) (4)
- Endovascular treatment for acute ischemic stroke in patients with versus without atrial fibrillation: a matched-control study (2021) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders. (2019) (4)
- Associations of Sleep Characteristics with Cerebrospinal Fluid sTREM2 in Cognitively Normal Older Adults: the CABLE Study (2021) (4)
- The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly. (2019) (4)
- Modifiable risk factors for incident dementia and cognitive impairment: An umbrella review of evidence. (2021) (4)
- Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis protocol (2020) (4)
- Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive function (2021) (4)
- Sleep Characteristics and Cognitive Function in Older Adults Without Dementia: The CABLE Study. (2021) (4)
- Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease (2021) (4)
- Social Isolation, Social Interaction, and Alzheimer's Disease: A Mendelian Randomization Study. (2021) (4)
- Plasma neurofilament light as a longitudinal biomarker of neurodegeneration in Alzheimer’s disease (2019) (3)
- A gene–environment interplay between omega‐3 supplementation and APOE ε4 provides insights for Alzheimer’s disease precise prevention amongst high‐genetic‐risk population (2021) (3)
- Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort. (2018) (3)
- Prospective biomarkers of Alzheimer’s disease: A systematic review and meta-analysis (2022) (3)
- Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease (2015) (3)
- Association between NME 8 Locus Polymorphism and Cognitive Decline , Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer ’ s Disease (2014) (3)
- Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy (2018) (3)
- Cataract, Cataract Surgery, and Risk of Incident Dementia: A Prospective Cohort Study of 300,823 Participants (2022) (3)
- Association of cerebral microbleeds with risks of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies (2021) (3)
- Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ42 decline in non-demented elders (2019) (3)
- Tea consumption and risk of incident dementia: A prospective cohort study of 377 592 UK Biobank participants (2022) (3)
- Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study. (2021) (3)
- Association of Long-term Exposure to Ambient Air Pollution With Cognitive Decline and Alzheimer’s Disease–Related Amyloidosis (2022) (3)
- Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders (2020) (3)
- P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders (2021) (3)
- Multi-Concept Frailty Predicts the Late-Life Occurrence of Cognitive Decline or Dementia: An Updated Systematic Review and Meta-Analysis of Longitudinal Studies (2022) (3)
- Prophylactic small dose amitriptyline in prevention of poststroke depression in first stroke patients (2010) (3)
- The Role of TDP-43 in Alzheimer’s Disease (2015) (2)
- Associations of Anxiety with Amyloid, Tau, and Neurodegeneration in Older Adults without Dementia: A Longitudinal Study. (2021) (2)
- Blood-based biomarkers in hypothalamic-pituitary axes for the risk of dementia or cognitive decline: a systematic review and meta-analysis (2020) (2)
- Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy (2014) (2)
- Left Ventricular Ejection Fraction and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Normal Older Adults: The CABLE Study. (2021) (2)
- Genome-Wide Association Study Identifies SLAMF1 Affecting the Rate of Memory Decline. (2020) (2)
- Evaluation relationships between subjective wellbeing, personality traits, and Alzheimer's disease: A two-sample Mendelian randomization study. (2021) (2)
- Mitochondrial dysfunction in Kennedy's disease: a new pharmacological target? (2015) (2)
- Associations of white matter hyperintensities with cognitive decline: A longitudinal study (2020) (2)
- Regional Amyloid Accumulation and White Matter Integrity in Cognitively Normal Individuals. (2020) (2)
- Tau Pathologies Mediate the Association of Cigarette Smoking with Cognitive Impairment in Older Adults Without Dementia: The CABLE Study. (2022) (2)
- Validation of external and internal exposome of the findings associated to cerebral small vessel disease: A Mendelian randomization study (2022) (2)
- Dose-response relationship between blood pressure and intracranial atherosclerotic stenosis. (2020) (2)
- Association of antinuclear antibodies with the risk of intracranial arterial stenosis (2020) (2)
- Socioeconomic Status and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 39 Prospective Studies (2022) (2)
- Clusterin polymorphisms and Alzheimer’s disease (2012) (2)
- Double-blind prospective randomized study comparing topical mupirocin and placebo for the prevention of infection associated with central venous catheters. (1997) (2)
- Insomnia Moderates the Relationship Between Amyloid-β and Cognitive Decline in Late-Life Adults without Dementia. (2021) (2)
- Impact of the disease management model of “treatment-education-follow-up” on anticoagulant therapy in patients with stroke and atrial fibrillation (2017) (2)
- Associations of grip strength, walking pace, and the risk of incident dementia: A prospective cohort study of 340212 participants (2022) (2)
- Associations of Vascular Risk with Cognition, Brain Glucose Metabolism, and Clinical Progression in Cognitively Intact Elders. (2021) (2)
- Associations of rs3740677 within GAB2 Gene with LOAD in Chinese Han Population (2017) (2)
- Associations of Physical Activity with Alzheimer's Disease Pathologies and Cognition: The CABLE Study. (2022) (2)
- Sleep duration and risk of cardio-cerebrovascular disease: A dose-response meta-analysis of cohort studies comprising 3.8 million participants (2022) (2)
- Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease (2022) (2)
- Tau Pathologies Mediate the Associations of Vascular Risk Burden with Cognitive Impairments in Non-demented Elders: The CABLE Study (2021) (2)
- sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer’s disease: The CABLE study (2022) (2)
- Genome-wide association study of white matter hyperintensity volume in elderly persons without dementia (2020) (2)
- Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study (2021) (2)
- Risk of seizures and subclinical epileptiform activity in patients with dementia: A systematic review and meta-analysis (2021) (2)
- Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy (2013) (1)
- Modifiable Risk Factors for Carotid Atherosclerosis: A Meta-analysis and Systematic Review (2019) (1)
- Association between multimorbidity status and incident dementia: a prospective cohort study of 245,483 participants (2022) (1)
- Peripheral Immune Cells and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. (2022) (1)
- Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria (2023) (1)
- An elevated platelet-to-lymphocyte ratio is associated with a higher risk of intracranial atherosclerotic stenosis (2022) (1)
- Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes (2020) (1)
- Blood pressure lowering and stroke prevention: a systematic review and network meta-analysis protocol. (2019) (1)
- An exploratory study on STX 6 , MOBP , MAPT , and EIF 2 AK 3 and late-onset Alzheimer ’ s disease (2015) (1)
- PET Amyloid and Tau Status Are Differently Affected by Patient Features. (2020) (1)
- FOUR NOVEL SUSCEPTIBILITY VARIANTS IDENTIFIED IN CHINESE ARE ASSOCIATED WITH SPORADIC ALZHEIMER’S DISEASE (2017) (1)
- Sleep Characteristics and Cerebrospinal Fluid Progranulin in Older Adults: The CABLE Study (2021) (1)
- Modified dementia risk score as a tool for the prediction of dementia: a prospective cohort study of 239745 participants (2022) (1)
- Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus (2014) (1)
- Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals (2021) (1)
- Common Variants in ABI3 Influence Cerebrospinal Fluid Total Tau Levels and Cognitive Decline in Progressive Mild Cognitive Impairment Patients. (2019) (1)
- Elevated Tau PET Signal Depends on Abnormal Amyloid Levels and Correlates with Cognitive Impairment in Elderly Persons without Dementia. (2020) (1)
- Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood (2022) (1)
- GENOME-WIDE ASSOCIATION STUDY IDENTIFIES ALZHEIMER'S RISK VARIANT IN MS4A6A INFLUENCING CEREBROSPINAL FLUID STREM2 LEVELS (2019) (1)
- Study on influencing factors and predictors of quality of life and family burden in patients with Alzheimer's disease (2018) (1)
- Serum Uric Acid Levels and Risk of Intracranial Atherosclerotic Stenosis: A Cross-Sectional Study (2020) (1)
- Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort (2022) (1)
- Pharmacological treatments for psychotic symptoms in dementia: A systematic review with pairwise and network meta-analysis (2022) (1)
- Investigating the association between cancer and dementia risk: a longitudinal cohort study (2022) (1)
- Neuroinflammation modulates the association of PGRN with cerebral amyloid-β burden (2021) (1)
- Deamidation-related blood biomarkers show promise for early diagnostics of neurodegeneration (2022) (1)
- Bridging integrator 1 (BIN1) genotypes Induce Alzheimer’s disease - related Brain atrophy, abnormal glucose and Aβ metabolisms in ADNI cohort (P2.159) (2015) (1)
- Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study (2021) (1)
- Causal Relations between Exposome and Stroke: A Mendelian Randomization Study (2022) (1)
- Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum (2022) (1)
- Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals: The CABLE Study (2021) (1)
- The Role of Reelin Signaling in Alzheimer’s Disease (2015) (1)
- The risk factors and prevention for Alzheimer's disease (2019) (1)
- Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies. (2022) (1)
- The future of stem cell therapies of Alzheimer’s disease (2022) (1)
- The role of the LRRK2 gene in Parkinsonism (2014) (1)
- Prevalence of the Preclinical Stages of Alzheimer's Disease in Cognitively Intact Older Adults: The CABLE Study. (2020) (1)
- Retraction Note: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis (2015) (1)
- Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial (2023) (1)
- HLA-A2 Alleles Mediate Alzheimer’s Disease by Altering Hippocampal Volume (2016) (0)
- Association of serum apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in elderly adults with subjective cognitive decline (2020) (0)
- Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology (2022) (0)
- MS4A Cluster in Alzheimer’s Disease (2014) (0)
- Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials (2018) (0)
- CD33 in Alzheimer's Disease (2013) (0)
- The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer’s Disease (2015) (0)
- PRIMARY AGE-RELATED TAUOPATHY: BIOLOGICAL DEFINITION AND LONGITUDINAL CLINICAL OUTCOME (2019) (0)
- Non-coding RNAs in Alzheimer's Disease (2012) (0)
- PREVALENCE AND LONGITUDINAL CLINICAL OUTCOMES OF ALZHEIMER’S ATN BIOMARKER PROFILES: A LONGITUDINAL STUDY (2019) (0)
- Retraction Note: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis (2016) (0)
- Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies (2015) (0)
- The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy (2015) (0)
- CR1 in Alzheimer's Disease (2014) (0)
- C9ORF72 Mutations in Neurodegenerative Diseases (2013) (0)
- Associations of resting heart rate with incident dementia, cognition, and brain structure: a prospective cohort study of UK biobank (2022) (0)
- Lung function and risk of incident dementia: A prospective cohort study of 431,834 individuals (2023) (0)
- The Role of Retromer in Alzheimer’s Disease (2015) (0)
- PGRN Alleviates Cerebral Amyloid-β Burden and Cognitive Impairments via Mediating Neuroinflammation (2020) (0)
- Herpesvirus infections and Alzheimer’s disease: a Mendelian randomization study (2021) (0)
- The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease (2015) (0)
- Spreading of Pathology in Alzheimer’s Disease (2017) (0)
- Residential greenness and risk of incident dementia: A prospective study of 375,342 participants. (2022) (0)
- S-Nitrosylation in Alzheimer's disease (2014) (0)
- Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders (2015) (0)
- Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer’s Disease (2015) (0)
- Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study (2021) (0)
- Association of thyroid disease with risks of dementia and cognitive impairment: A meta-analysis and systematic review (2023) (0)
- Amyloid-β Induces NLRP1-Dependent Neuronal Pyroptosis in Alzheimer's Disease (P1.239) (2014) (0)
- Influence of social networks on Alzheimer’s disease biomarkers and subjective cognitive decline among elders without dementia: A CABLE study (2020) (0)
- Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia (2020) (0)
- Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases (2014) (0)
- Renal function and neurodegenerative diseases : a two-sample Mendelian randomization study (2023) (0)
- The Association of Serum Uric Acid Level, Gout, and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study. (2022) (0)
- A Missense Variant in TREML2 Reduces Risk of Alzheimer’s Disease in a Han Chinese Population (2016) (0)
- Association of serum apolipoprotein B with cerebrospinal fluid Alzheimer’s disease biomarkers in patients with subjective cognitive decline (2020) (0)
- Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study (2020) (0)
- Association of DISC1 Polymorphisms with Late-Onset Alzheimer’s Disease in Northern Han Chinese (2016) (0)
- FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study (2019) (0)
- TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice (2016) (0)
- TREM2 Knockdown Exacerbates Aging-Related Neuroinflammation And Cognitive Deficiency In SAMP8 Mice (P1.241) (2014) (0)
- Association of plasma apolipoprotein B with cerebrospinal fluid Alzheimer’s disease biomarkers in patients with subjective cognitive decline (2019) (0)
- The Role of PICALM in Alzheimer’s Disease (2014) (0)
- Ischemic Preconditioning Provides Neuroprotection by Induction of AMP-Activated Protein Kinase-Dependent Autophagy in a Rat Model of Ischemic Stroke (2014) (0)
- Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease. (2023) (0)
- Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET (2021) (0)
- Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies (2015) (0)
- Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression. (2023) (0)
- A Candidate Regulatory Variant at the TREM Gene Cluster Confer Alzheimer’s Disease Risk by Modulating Both Amyloid-β Pathology and Neuronal Degeneration (2019) (0)
- Elevated Hs-CRP Levels Are Associated with Higher Risk of Intracranial Arterial Stenosis (2019) (0)
- The Role of SORL1 in Alzheimer’s Disease (2014) (0)
- Association of TOMM40 Polymorphisms with Late-Onset Alzheimer’s Disease in a Northern Han Chinese Population (2013) (0)
- The genetic risk effects of APOE ε4 and novel variants on Chinese familial and sporadic AD (2021) (0)
- Cerebrospinal fluid heart fatty acid‐binding protein as a predictive biomarker of neurodegeneration in Alzheimer’s disease (2021) (0)
- A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid (2018) (0)
- The Role of PGRN in Alzheimer’s Disease (2015) (0)
- PLD3 in Alzheimer’s Disease (2014) (0)
- Identification of novel drug targets for the risk and prognosis of COVID-19 (2021) (0)
- Autophagy Modulation for Alzheimer’s Disease Therapy (2013) (0)
- Endoplasmic Reticulum Dysfunction in Alzheimer’s Disease (2014) (0)
- Retraction: DNAJC6 variants in Parkinson's disease and amyotrophic lateral sclerosis. (2016) (0)
- Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies (P3.094) (2017) (0)
- The Role of Cholesterol Metabolism in Alzheimer’s Disease (2014) (0)
- Serum Uric Acid Levels and Risk of Intracranial Atherosclerotic Stenosis: A Cross-Sectional Study (2020) (0)
- Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study. (2023) (0)
- Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid-soluble TREM2. (2023) (0)
- Causal effects of serum sex hormone binding protein levels on the risk of amyotrophic lateral sclerosis: a mendelian randomization study (2022) (0)
- Corrigendum to “Common variant in PTK2B is associated with late-onset Alzheimer’s disease: A replication study and meta-analyses” [Neurosci. Lett. 621 (2016) 83–87] (2016) (0)
- Multipredictor risk models for predicting individual risk of Alzheimer’s disease (2020) (0)
- The genetic architecture of human amygdala volumes and their overlap with common brain disorders (2023) (0)
- Cognitive Reserve and Alzheimer’s Disease (2014) (0)
- A panel of blood lipids associated with cognitive performance, brain atrophy and diagnosis: A longitudinal study of elders without dementia (2020) (0)
- Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy. (2023) (0)
- Inhibition of caspase-1 ameliorates tauopathy and rescues cognitive impairment in SAMP8 mice (2022) (0)
- Disease trajectories in elders with suspected non-Alzheimer’s pathophysiology and its comparison with Alzheimer’s disease pathophysiology: a longitudinal study (2023) (0)
- Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease (2022) (0)
- Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study (2022) (0)
- Characteristics of Subjective Cognitive Decline Associated with Alzheimer’s Disease Amyloid Pathology: Findings from The CABLE Study (2023) (0)
- P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders (2021) (0)
- Enhance the prevention and treatment of vascular cognitive impairment (2011) (0)
- Retraction: ‘DNAJC6 variants in Parkinson's disease and amyotrophic lateral sclerosis’ by Jiang, T., Zhang, Y‐D., Tan, L., and Yu, J‐T. (2016) (0)
- Endovascular Treatment Versus Intravenous Thrombolysis for Acute Ischemic Stroke: a Quantitative Review and Meta-Analysis of 21 Randomized Trials (2016) (0)
- The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy (2012) (0)
- Association between Life’s Simple 7 and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study (2022) (0)
- Association between Kidney Function and the Burden of Cerebral Small Vessel Disease: An Updated Meta-Analysis and Systematic Review. (2023) (0)
- Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders (2020) (0)
- SORL1 Is Associated with the Risk of Late-Onset Alzheimer’s Disease: a Replication Study and Meta-Analyses (2016) (0)
- Axonal Transport Defects in Alzheimer’s Disease (2014) (0)
- Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum (2015) (0)
- sTREM2 and GFAP Mediated the Association of IGF-1 Signaling Biomarkers with Alzheimer's Disease Pathology. (2023) (0)
- The Role of Cdk5 in Alzheimer’s Disease (2015) (0)
- Association between Life’s Simple 7 and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study (2022) (0)
- Plasma β2-microglobulin and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study (2023) (0)
- TREM2 in Alzheimer’s disease (2013) (0)
- A Multi-Dimensional Comparison of Alzheimer's Disease Neurodegenerative Biomarkers. (2022) (0)
- Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment (2016) (0)
- Genetic Association of SLC2A14 Polymorphism with Alzheimer’s Disease in a Han Chinese Population (2012) (0)
- Plasma (2021) (0)
- β-Arrestins as Potential Therapeutic Targets for Alzheimer’s Disease (2013) (0)
- Heart fatty acid-binding protein is associated with phosphorylated tau and longitudinal cognitive changes (2022) (0)
- The risk factors and prevention of Parkinson's disease (2019) (0)
- Cerebrospinal Fluid α-Synuclein Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease (2020) (0)
- BPV associated with imaging features of SSI on MRI (2020) (0)
- Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer’s Disease Cohorts (2016) (0)
- Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease. (2022) (0)
- Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration (2021) (0)
- A Mitocentric View of Alzheimer’s Disease (2016) (0)
- Genome-Wide Association Study of Cerebral Microbleeds on MRI (2019) (0)
- Cerebrospinal fluid α-synuclein as a potential biomarker for Alzheimer’s disease (P4.174) (2018) (0)
- TYROBP in Alzheimer’s Disease (2014) (0)
- Isoaspartate as a biomarker for early diagnostics of neurodegenerative diseases (2022) (0)
- Retraction: Yu et al. Retraction. (2016) (0)
- GWAS-Linked Loci and Neuroimaging Measures in Alzheimer’s Disease (2016) (0)
- Genome-wide association study identifies APOE locus influencing plasma p-tau181 levels (2022) (0)
- Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review. (2023) (0)
- Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer’s Disease (2016) (0)
- ABCA7 in Alzheimer’s Disease (2014) (0)
- The Association Between Osteoarthritis with Risk of Dementia and Cognitive Impairment: A Meta-Analysis and Systematic Review. (2022) (0)
- Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies (2015) (0)
- PGRN Is Associated with Late-Onset Alzheimer’s Disease: a Case–Control Replication Study and Meta-analysis (2016) (0)
- Age-dependent association of KIBRA gene polymorphism with Alzheimer’s disease in Han Chinese (2013) (0)
- Association of the Tauopathy GWAS Loci with Alzheimer's Disease in China (P04.220) (2013) (0)
- The NLRP3 Inflammasome in Alzheimer’s Disease (2013) (0)
- Correction to: Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort (2022) (0)
- Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia (2014) (0)
- Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese (2013) (0)
- RETRACTED ARTICLE: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis (2015) (0)
- Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases (2014) (0)
- Associations of Life's Simple 7 with cerebral white matter hyperintensities and microstructural integrity: UK Biobank cohort study (2023) (0)
- Association of Parkinson’s Disease GWAS-Linked Loci with Alzheimer’s Disease in Han Chinese (2016) (0)
- Genome-wide association study identifies two loci influencing plasma neurofilament light levels (2018) (0)
- Association of Cerebral Small Vessel Disease Burden with Neuropsychiatric Symptoms in Non-Demented Elderly: A Longitudinal Study. (2022) (0)
- A new ERBB4 variant in amyotrophic lateral sclerosis type 19: Case report and review of the literature (2023) (0)
- Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy (2023) (0)
- Associations of rs3740677 within GAB2 Gene with LOAD in Chinese Han Population (2016) (0)
- Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease (2022) (0)
- NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model (2015) (0)
- Infarct location predicts progressive motor deficits in patients with infarct in the perforator territory of the middle cerebral artery (2015) (0)
- Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer’s Disease in Han Chinese (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lan Tan?
Lan Tan is affiliated with the following schools:
